Welcome to our dedicated page for Profound Med news (Ticker: PROF), a resource for investors and traders seeking the latest updates and insights on Profound Med stock.
Profound Medical Corp (PROF) delivers innovative MRI-guided therapeutic solutions for prostate ablation, merging precision imaging with minimally invasive treatment. This news hub provides investors and healthcare professionals with timely updates on clinical advancements, regulatory milestones, and corporate developments shaping the future of image-guided therapies.
Access verified information on PROF's TULSA-PRO system adoption, partnership announcements, and financial performance. Our curated news collection features earnings reports, research publications, and market analysis to help stakeholders track the company's progress in advancing non-invasive treatment options.
Key coverage areas include FDA clearances, clinical trial outcomes, technology enhancements, and strategic collaborations. Stay informed about developments in therapeutic ultrasound applications and the growing adoption of closed-loop thermal control systems in urology practices worldwide.
Bookmark this page for direct access to primary source materials and expert commentary on PROF's role in transforming prostate cancer treatment paradigms through cutting-edge medical device innovation.
Profound Medical Corp. (NASDAQ:PROF) will release its first quarter 2023 financial results after the market closes on May 10, 2023. A conference call is scheduled for the same day at 4:30 p.m. ET, where management will review the financial outcomes and discuss recent business developments. Profound is known for its incision-free therapies for the ablation of diseased tissue, notably its TULSA-PRO® technology, which offers customizable, radiation-free treatments for prostate issues. The company has also commercialized Sonalleve®, a platform for treating uterine fibroids and palliative pain in bone metastases, which holds multiple regulatory approvals including FDA clearance.
FAQ
What is the current stock price of Profound Med (PROF)?
What is the market cap of Profound Med (PROF)?
